Thomas Kaasgaard Email

Senior Manager, CMC Formulation . Cerecin previously Accera

Current Roles

Cerecin, previously Accera, Inc., is a global healthcare company focused on developing brain health solutions and therapeutics for patients around the world. Cerecin is led by an expert executive management team with globally recognized specialists in central nervous system diseases and supported by two partners, Nestle Group and Wilmar Ventures Pte. Ltd. Cerecin's lead compound, tricaprilin, is intended to address the metabolic deficit that is known to be characteristic of Alzheimer's disease by providing the brain with an alternative energy substrate. Cerecin is currently preparing this newly reformulated compound for global pivotal studies. Bringing together the deep industry expertise of its leadership team and the extensive market access capabilities of its strategic investors, Cerecin is growing its global presence to build a brighter future for Alzheimer's patients.
Cerecin previously Accera Address
44 Cook Street
Denver, CO
United States
Cerecin previously Accera Email
Cerecin previously Accera Phone Numbers

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.